Contact
Please use this form to send email to PR contact of this press release:
Oxidien Announces Publication of Clinical Results Demonstrating Significant Reduction in Urinary Oxalate
TO:
Helena Cowley
Oxidien Pharmaceuticals, LLC
+1 352-672-5320